Studies Show Famvir as an Effective Treatment

by Jennifer Alinio - Date: 2007-03-15 - Word Count: 218 Share This!

In a double-blind, acyclovir controlled multicenter study, 148 immunocompromised patients (bone marrow transplant recipients and cancer patients) with herpes zoster were randomized to receive either Famvir 500mg three times daily or acyclovir 800 mg five times daily for ten days. The median time to complete healing of all lesions was comparable for patients treated with either Famvir or acyclovir. In addition, there were no significant differences between both treatment groups in times to loss of lesion associated symptoms or new lesion formation.
Famvir is indicated for the treatment of recurrent genital herpes and acute herpes zoster in immunocompetent individuals. SmithKline Beecham has filed a new drug application with the FDA for the use of penciclovir IV in the treatment of mucocutaneous herpes simplex and herpes zoster infections in immunocompromised individuals. Other studies are ongoing to evaluate the use of Famvir in the treatment of herpes virus infections in immunocompetent and immunocompromised individuals. In addition, studies are ongoing in the treatment of chronic hepatitis B virus infection.

There are so many sites devoting the attention to the promotion of this drug too. is one of the trusted sources of this product. Visit for more details. Online Drug Store

The online drug store that provides a wide range of services such as drug information, health care products and prescription medication online.

Related Tags: online pharmacy, weight loss pill, discount drug store, tramadol, sexual health, drug store pharmacy, online drug store, health medicines, health product, medicare prescription drug, medicine shops, womans health, soma, sleeping aids, fioricet, buy fioricet online, buy soma, cheap soma, cheap tramadol

Your Article Search Directory : Find in Articles

© The article above is copyrighted by it's author. You're allowed to distribute this work according to the Creative Commons Attribution-NoDerivs license.

Recent articles in this category:

Most viewed articles in this category: